泪道逆行插管联合鱼腥草注射液冲洗泪道治疗慢性泪囊炎  被引量:1

Treatment of Chronic Dacryocystitis with Recessive Placement of Nasolacrimal Stent Combined with Yuxingcao Injection Lacrimal Duct Lavage

在线阅读下载全文

作  者:欧阳丽[1] 李杜军[1] 罗继红[1] 胡军[2] 

机构地区:[1]湖北省中医院眼科,湖北武汉430061 [2]华中科技大学同济医学院附属同济医院眼科,湖北武汉430022

出  处:《武汉大学学报(医学版)》2014年第5期736-739,共4页Medical Journal of Wuhan University

基  金:教育部科研基金项目(编号:2013-1792);湖北省自然科学基金项目(编号:2012FFB02304)

摘  要:目的:观察泪道逆行插管联合鱼腥草注射液冲洗泪道治疗慢性泪囊炎的临床疗效。方法:临床收集的慢性泪囊炎患者176例(205眼),随机分成2组,治疗组(A组)73例(83眼),对照组(B组)103例(122眼)。局麻下行逆行泪道插管术,A组术后加用鱼腥草注射液冲洗泪道;根据患者病情或患者要求置管至少保留半年以上,拔管后,泪道注入妥布霉素地塞米松眼膏3-5次,并定期冲洗泪道;随访6月至3年,平均1.5年。结果:A组治愈率为77.11%,B组治愈率为66.39%,两组治愈率经统计学分析差异有统计学意义(χ2=2.946,P<0.01)。结论:鼻泪管逆植球头硅胶管联合鱼腥草注射液冲洗治疗慢性泪囊炎,操作简便,痛苦小、面部不留疤痕,既经济又无明显毒副作用,成功率较高,值得推广使用。Objective:To abserve the clinical efficacy of recessive placement of nasolacrimal stent combined with Yuxingcao injection lacrimal duct lavage in the treatment of chronic dacryocystitis.Methods:176patients(205eyes)with chronic dacryocystitis has been divided to two groups randomly as 73subjects(83eyes)in combined Yuxingco lavage group(A group)and 103subjects(122eyes)in conventional lavage group(B group).The stents were removed more than six months postoperatively.After stents removed,the tobramycin + dexamethasone eye ointment was injected in lacrimal passages 3-5times.All patients received regular lacrimal duct lavage.The patients were followed-up 6months to 3years(1.5years in average).Results:The complete success rate was 77.11%in A group.The complete success rate was 66.39%in B group.The overall cure rate difference between the two groups were significantly(χ2=2.946,P〈0.01).Conclusion:Recessive placement of nasolacrimal stent combined with Yuxingcao Injection lacrimal duct lavage is a simple,effective and safe technique in the treatment of chronic dacryocystitis.

关 键 词:慢性泪囊炎 泪道插管 鱼腥草注射液 

分 类 号:R777.2[医药卫生—眼科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象